BIOTELM-CH40

Telmisartan 40mg+Chlorthaildone12.5mg Tablets

• Reduce risk of HF by 49% and risk of MI by 33%.
• More effective in preventing CHF and CHD
• Only ARB indicated to reduce CV morbidity and mortality i high risk patients.
• CTD has more favourable pleiotropic effects relating to platelet aggregation and angiogenesis.
• First Line Treatment in stage || Hypertension with High CV Risk